406 related articles for article (PubMed ID: 21917861)
1. Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors.
Arlt W; Biehl M; Taylor AE; Hahner S; Libé R; Hughes BA; Schneider P; Smith DJ; Stiekema H; Krone N; Porfiri E; Opocher G; Bertherat J; Mantero F; Allolio B; Terzolo M; Nightingale P; Shackleton CH; Bertagna X; Fassnacht M; Stewart PM
J Clin Endocrinol Metab; 2011 Dec; 96(12):3775-84. PubMed ID: 21917861
[TBL] [Abstract][Full Text] [Related]
2. Simplified urinary steroid profiling by LC-MS as diagnostic tool for malignancy in adrenocortical tumors.
Vogg N; Müller T; Floren A; Dandekar T; Riester A; Dischinger U; Kurlbaum M; Kroiss M; Fassnacht M
Clin Chim Acta; 2023 Mar; 543():117301. PubMed ID: 36948238
[TBL] [Abstract][Full Text] [Related]
3. Urine Steroid Metabolomics as a Novel Tool for Detection of Recurrent Adrenocortical Carcinoma.
Chortis V; Bancos I; Nijman T; Gilligan LC; Taylor AE; Ronchi CL; O'Reilly MW; Schreiner J; Asia M; Riester A; Perotti P; Libé R; Quinkler M; Canu L; Paiva I; Bugalho MJ; Kastelan D; Dennedy MC; Sherlock M; Ambroziak U; Vassiliadi D; Bertherat J; Beuschlein F; Fassnacht M; Deeks JJ; Biehl M; Arlt W
J Clin Endocrinol Metab; 2020 Mar; 105(3):e307-18. PubMed ID: 31665449
[TBL] [Abstract][Full Text] [Related]
4. Different Types of Urinary Steroid Profiling Obtained by High-Performance Liquid Chromatography and Gas Chromatography-Mass Spectrometry in Patients with Adrenocortical Carcinoma.
Velikanova LI; Shafigullina ZR; Lisitsin AA; Vorokhobina NV; Grigoryan K; Kukhianidze EA; Strelnikova EG; Krivokhizhina NS; Krasnov LM; Fedorov EA; Sablin IV; Moskvin AL; Bessonova EA
Horm Cancer; 2016 Dec; 7(5-6):327-335. PubMed ID: 27370636
[TBL] [Abstract][Full Text] [Related]
5. High-Resolution, Accurate-Mass (HRAM) Mass Spectrometry Urine Steroid Profiling in the Diagnosis of Adrenal Disorders.
Hines JM; Bancos I; Bancos C; Singh RD; Avula AV; Young WF; Grebe SK; Singh RJ
Clin Chem; 2017 Dec; 63(12):1824-1835. PubMed ID: 28814383
[TBL] [Abstract][Full Text] [Related]
6. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.
Sbiera S; Schmull S; Assie G; Voelker HU; Kraus L; Beyer M; Ragazzon B; Beuschlein F; Willenberg HS; Hahner S; Saeger W; Bertherat J; Allolio B; Fassnacht M
J Clin Endocrinol Metab; 2010 Oct; 95(10):E161-71. PubMed ID: 20660055
[TBL] [Abstract][Full Text] [Related]
7. Serum inhibin pro-αC is a tumor marker for adrenocortical carcinomas.
Hofland J; Feelders RA; van der Wal R; Kerstens MN; Haak HR; de Herder WW; de Jong FH
Eur J Endocrinol; 2012 Feb; 166(2):281-9. PubMed ID: 22127493
[TBL] [Abstract][Full Text] [Related]
8. Use of urinary steroid profiling for diagnosing and monitoring adrenocortical tumours.
Tiu SC; Chan AO; Taylor NF; Lee CY; Loung PY; Choi CH; Shek CC
Hong Kong Med J; 2009 Dec; 15(6):463-70. PubMed ID: 19966352
[TBL] [Abstract][Full Text] [Related]
9. Plasma steroid metabolome profiling for the diagnosis of adrenocortical carcinoma.
Schweitzer S; Kunz M; Kurlbaum M; Vey J; Kendl S; Deutschbein T; Hahner S; Fassnacht M; Dandekar T; Kroiss M
Eur J Endocrinol; 2019 Feb; 180(2):117-125. PubMed ID: 30481155
[TBL] [Abstract][Full Text] [Related]
10. Steroid profiling in adrenal disease.
Mu D; Sun D; Qian X; Ma X; Qiu L; Cheng X; Yu S
Clin Chim Acta; 2024 Jan; 553():117749. PubMed ID: 38169194
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic features and expression of epidermal growth factor receptor and vascular endothelial growth factor in adrenocortical tumors].
Wang CP; Zhang J; Gao J; Liu PP; Wu SF; Zeng X; Liang ZY
Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):686-90. PubMed ID: 23302311
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of a malignant adrenal mass: the role of urinary steroid metabolite profiling.
Bancos I; Arlt W
Curr Opin Endocrinol Diabetes Obes; 2017 Jun; 24(3):200-207. PubMed ID: 28234802
[TBL] [Abstract][Full Text] [Related]
13. Sum of High-Risk Gene Mutation (SHGM): A Novel Attempt to Assist Differential Diagnosis for Adrenocortical Carcinoma with Benign Adenoma, Based on Detection of Mutations of Nine Target Genes.
Zheng GY; Zhang XB; Li HZ; Zhang YS; Deng JH; Wu XC
Biochem Genet; 2021 Aug; 59(4):902-918. PubMed ID: 33564960
[TBL] [Abstract][Full Text] [Related]
14. A 13-Steroid Serum Panel Based on LC-MS/MS: Use in Detection of Adrenocortical Carcinoma.
Taylor DR; Ghataore L; Couchman L; Vincent RP; Whitelaw B; Lewis D; Diaz-Cano S; Galata G; Schulte KM; Aylwin S; Taylor NF
Clin Chem; 2017 Dec; 63(12):1836-1846. PubMed ID: 28904054
[TBL] [Abstract][Full Text] [Related]
15. Protein Expression of PTTG1 as a Diagnostic Biomarker in Adrenocortical Carcinoma.
Romero Arenas MA; Whitsett TG; Aronova A; Henderson SA; LoBello J; Habra MA; Grubbs EG; Lee JE; Sircar K; Zarnegar R; Scognamiglio T; Fahey TJ; Perrier ND; Demeure MJ
Ann Surg Oncol; 2018 Mar; 25(3):801-807. PubMed ID: 29218429
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Value of Urinary Steroid Profiling in the Evaluation of Adrenal Tumors.
Kerkhofs TM; Kerstens MN; Kema IP; Willems TP; Haak HR
Horm Cancer; 2015 Aug; 6(4):168-75. PubMed ID: 25985881
[TBL] [Abstract][Full Text] [Related]
17. Proteome analysis of adrenal cortical tumors.
Kim HM; Lee YK; Koo JS
Expert Rev Proteomics; 2016 Aug; 13(8):747-55. PubMed ID: 27385106
[TBL] [Abstract][Full Text] [Related]
18. IGF2 role in adrenocortical carcinoma biology.
Pereira SS; Monteiro MP; Costa MM; Moreira Â; Alves MG; Oliveira PF; Jarak I; Pignatelli D
Endocrine; 2019 Nov; 66(2):326-337. PubMed ID: 31378849
[TBL] [Abstract][Full Text] [Related]
19. Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study.
Bancos I; Taylor AE; Chortis V; Sitch AJ; Jenkinson C; Davidge-Pitts CJ; Lang K; Tsagarakis S; Macech M; Riester A; Deutschbein T; Pupovac ID; Kienitz T; Prete A; Papathomas TG; Gilligan LC; Bancos C; Reimondo G; Haissaguerre M; Marina L; Grytaas MA; Sajwani A; Langton K; Ivison HE; Shackleton CHL; Erickson D; Asia M; Palimeri S; Kondracka A; Spyroglou A; Ronchi CL; Simunov B; Delivanis DA; Sutcliffe RP; Tsirou I; Bednarczuk T; Reincke M; Burger-Stritt S; Feelders RA; Canu L; Haak HR; Eisenhofer G; Dennedy MC; Ueland GA; Ivovic M; Tabarin A; Terzolo M; Quinkler M; Kastelan D; Fassnacht M; Beuschlein F; Ambroziak U; Vassiliadi DA; O'Reilly MW; Young WF; Biehl M; Deeks JJ; Arlt W;
Lancet Diabetes Endocrinol; 2020 Sep; 8(9):773-781. PubMed ID: 32711725
[TBL] [Abstract][Full Text] [Related]
20. A Diagnostic Approach to Adrenocortical Tumors.
Hodgson A; Pakbaz S; Mete O
Surg Pathol Clin; 2019 Dec; 12(4):967-995. PubMed ID: 31672302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
